VeriMomIst garcinia mangostana peel extract in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive hazard; peer‑reviewed literature contains pharmacology/toxicity studies but no consistent in vivo reproductive/teratology data indicating teratogenicity. Topical cosmetic exposure is expected to give low but measurable systemic exposure for typical extract constituents (PubChem/CosIng data), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised classification), PubMed (no clear reproductive/teratology evidence), PubChem/CosIng.
Pregnancy-safe products containing garcinia mangostana peel extract
Related ingredients
Frequently asked questions
- Ist garcinia mangostana peel extract in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive hazard; peer‑reviewed literature contains pharmacology/toxicity studies but no consistent in vivo reproductive/teratology data indicating teratogenicity. Topical cosmetic exposure is expected to give low but measurable systemic exposure for typical extract constituents (PubChem/CosIng data), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised classification), PubMed (no clear reproductive/teratology evidence), PubChem/CosIng.
- Ist garcinia mangostana peel extract während des Stillens sicher?
- No authoritative evidence of reproductive or lactation-specific toxicity or harmonised hazard classifications. Lipophilic small molecules in extracts could theoretically transfer into milk if systemically absorbed, but no data demonstrating this for mangosteen peel extract or major xanthones; therefore hazard and mechanism remain 0 and exposure scored as low (1). Sources: ECHA Annex VI, PubMed, PubChem/CosIng.
- Ist garcinia mangostana peel extract sicher für Babyhaut?
- No infant-specific reproductive or developmental toxicity data found; no regulatory flags. Because infant skin has higher absorption (immature barrier, higher surface‑area‑to‑weight), exposure rating increased by +1 relative to adults (adult exposure scored 1 → infant 2). No evidence to change hazard or mechanism. Sources: PubMed (no infant toxicity data), CosIng/PubChem (ingredient identity/properties), ECHA Annex VI (no harmonised classification).
- Wie bewertet VeriMom garcinia mangostana peel extract?
- VeriMom bewertet garcinia mangostana peel extract mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu garcinia mangostana peel extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu garcinia mangostana peel extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.